RxSight (RXST) EBITDA Yield: History & Chart

RxSight, Inc.(RXST)

Medical - Devices · Aliso Viejo, CA

$4.65-0.11 (-2.31%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About RxSight, Inc.

As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.

Aliso Viejo, CA

461 employees

www.rxsight.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Aziz Mottiwala

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
RxSight, Inc. (RXST)	$192.49M	N/A	N/A	N/A	N/A
Zentalis Pharmaceuticals, Inc. (ZNTL)vs ›	$190.07M	N/A	N/A	N/A	N/A
Eledon Pharmaceuticals, Inc. (ELDN)vs ›	$189.11M	N/A	N/A	N/A	N/A
Surrozen, Inc. (SRZN)vs ›	$197.18M	N/A	N/A	N/A	N/A
Exagen Inc. (XGN)vs ›	$197.87M	N/A	N/A	N/A	N/A
Cartesian Therapeutics, Inc. (RNAC)vs ›	$198.33M	N/A	27.87%	27.87%	27.87%
Alector, Inc. (ALEC)vs ›	$200.96M	N/A	6.19%	6.19%	6.19%
AN2 Therapeutics, Inc. (ANTX)vs ›	$182.60M	N/A	N/A	N/A	N/A
Canton Strategic Holdings Inc (CNTN)vs ›	$180.47M	N/A	N/A	N/A	N/A
Compass Therapeutics, Inc. (CMPX)vs ›	$179.75M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EBITDA YIELD

TTM

RxSight, Inc. (RXST)

$192.49M

N/A

Zentalis Pharmaceuticals, Inc. (ZNTL)vs ›

$190.07M

N/A

Eledon Pharmaceuticals, Inc. (ELDN)vs ›

$189.11M

N/A

Surrozen, Inc. (SRZN)vs ›

$197.18M

N/A

Exagen Inc. (XGN)vs ›

$197.87M

N/A

Cartesian Therapeutics, Inc. (RNAC)vs ›

$198.33M

N/A

27.87%

Alector, Inc. (ALEC)vs ›

$200.96M

N/A

6.19%

AN2 Therapeutics, Inc. (ANTX)vs ›

$182.60M

N/A

Canton Strategic Holdings Inc (CNTN)vs ›

$180.47M

N/A

Compass Therapeutics, Inc. (CMPX)vs ›

$179.75M

N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

RXST EBITDA Yield Metrics

RXST Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics